Merck’s antiviral pill reduces hospitalization of Covid patients, a possible game-changer for treatment

01 Ottobre 2021

An investigational antiviral pill reduced the chances that patients newly diagnosed with Covid-19 would be hospitalized by about 50%, a finding that could give doctors a desperately needed new way to treat the sick, the drug maker Merck announced Friday.


Continua la lettura dell’articolo

Avviso sui cookie di WordPress da parte di Real Cookie Banner